Listed

Quantum Corp: Form 10-Q for the period ended Dec 31, 2024

Filed with the SEC on Feb 12, 2025 and accepted by EDGAR at Feb 12, 2025, 22:06 ET.

Share

Management's discussion and analysis

As filed, 28,190 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis compares the change in the consolidated financial statements for quarters ending December 31, 2024 and December 31, 2023 and should be read together with our consolidated financial statements, the accompanying notes, and other information included in this Quarterly Report. In particular, the risk factors contained in Part II, Item 1A may reflect trends, demands, commitments, events, or uncertainties that could materially impact our results of operations and liquidity and capital resources. For comparisons of quarters ended December 31, 2023 and December 31, 2022*, see our Management's Discussion and Analysis of Financial Condition and Results of Operations in Item 2 of our Quarterly Report on Form 10-Q for the quarter ended* December 31, 2023*, filed with the SEC on September 6, 2024, and incorporated herein by reference. Our fiscal year ends on March 31 of each calendar year. "Fiscal 2024" refers to the fiscal year ended March 31, 2024.*

The following discussion contains forward-looking statements, such as statements regarding anticipated impacts on our business, our future operating results and financial position, our business strategy and plans, our market growth and trends, and our objectives for future operations. Please see "Note Regarding Forward-Looking Statements" for more information about relying on these forward-looking statements.

OVERVIEW

We are a technology company whose mission is to deliver innovative solutions to organizations across the world. We design, manufacture and sell technology and services that help customers capture, create and share digital content, and protect it for decades. We emphasize innovative technology in the design and manufacture of our products to help our customers unlock the value in their video and unstructured data in new ways to solve their most pressing business challenges.

We generate revenue by designing, manufacturing, and selling technology and services. Our most significant expenses are related to compensating employees; designing, manufacturing, marketing, and selling our products and services; data center costs in support of our cloud-based services; and interest associated with our long-term debt and income taxes.

Macroeconomic Conditions

We continue to actively monitor, evaluate and respond to the current uncertain macro environment, including the impact of higher interest rates, inflation, tariffs, lingering supply chain challenges, and a stronger U.S. dollar. During the quarter we continued to experience longer sales cycle for opportunities with our enterprise as well as commercial customers.

The macro environment remains unpredictable and our past results may not be indicative of future performance.

RESULTS OF OPERATIONS

(in thousands)

Three Months Ended December 31, 2024 2023 Nine Months Ended December 31, 2024 2023
Total revenue $72,551 $71,926 $214,364 $240,099
Total cost of revenue (1) 40,796 42,745 127,205 142,543
Gross profit 31,755 29,181 87,159 97,556
Operating expenses
Sales and marketing (1) 12,448 14,244 39,321 45,800
General and administrative (1) 14,142 11,893 49,186 34,833
Research and development (1) 7,683 8,763 24,255 28,828
Restructuring charges (1) 1,342 497 2,916 3,164
Total operating expenses 35,615 35,397 115,678 112,625
Loss from operations (3,860) (6,216) (28,519) (15,069)
Other income (expense), net 967 (1,419) (408) (2,049)
Interest expense (6,840) (3,937) (16,761) (10,992)
Change in fair value of warrant liabilities (61,630) 2,213 (56,414) 7,341
Loss on debt extinguishment — — (3,003) —
Net loss before income taxes (71,363) (9,359) (105,105) (20,769)
Income tax provision 70 510 675 1,573
Net loss $(71,433) $(9,869) $(105,780) $(22,342)

(1) Includes stock-based compensation as follows:

(in thousands)

Three Months Ended December 31, 2024 2023 Nine Months Ended December 31, 2024 2023
Cost of revenue $95 $195 $361 $576
Research and development 105 325 454 989
Sales and marketing 46 (123) 219 516
General and administrative 490 509 1,342 1,657
Total $736 $906 $2,376 $3,738

Comparison of the Three Months Ended December 31, 2024 and 2023

Revenue

(dollars in thousands)

Three Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Product revenue $38,610 53% $37,113 51% $1,497 4%
Service and subscription 31,615 44% 32,771 46% (1,156) (4)%
Royalty 2,326 3% 2,042 3% 284 14%
Total revenue $72,551 100% $71,926 100% $625 1%

Product Revenue

In the three months ended December 31, 2024, product revenue increased $1.5 million, or 4%, as compared to the same period in fiscal 2024. The primary driver of the increase was in Primary storage systems with higher sales of our StorNext based solutions.

Service and Subscription Revenue

Service and subscription revenue decreased $1.2 million, or 4%, in the three months ended December 31, 2024 compared to the same period in fiscal 2024. This decrease was due to certain long-lived products reaching their end-of-service-life.

Royalty Revenue

We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue saw a small increase of $0.3 million, or 14%, in the three months ended December 31, 2024 compared to the same period in fiscal 2024 due to product mix.

Gross Profit and Margin

(dollars in thousands)

Three Months Ended December 31, 2024 Gross margin % 2023 Gross margin % $ Change Basis point change
Product $7,688 19.9% $7,069 19.0% $619 90
Service and subscription 21,741 68.8% 20,070 61.2% 1,671 760
Royalty 2,326 100.0% 2,042 100.0% 284 —
Gross profit $31,755 43.8% $29,181 40.6% $2,574 320

Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.

Product Gross Margin

Product gross margin increased by $0.6 million, or by 90 basis points, for the three months ended December 31, 2024, as compared with the same period in fiscal 2024. This increase was primarily due to a more favorable mix of revenues, weighted towards our higher margin product lines, as well as improvements in our operational efficiency and logistics costs.

Service and Subscription Gross Margin

Service and subscription gross margins increased 760 basis points for the three months ended December 31, 2024, as compared with the same period in fiscal 2024. This increase was primarily driven by improvements in our operations efficiency.

Royalty Gross Margin

Royalties do not have significant related cost of sales.

Operating Expenses

(dollars in thousands)

Three Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Sales and marketing $12,448 17% $14,244 20% $(1,796) (13)%
General and administrative 14,142 19% 11,893 17% 2,249 19%
Research and development 7,683 11% 8,763 12% (1,080) (12)%
Restructuring charges 1,342 2% 497 1% 845 170%
Total operating expenses $35,615 49% $35,397 49% $218 1%

In the three months ended December 31, 2024, sales and marketing expenses decreased $1.8 million, or 13%, as compared with the same period in fiscal 2024. This decrease was primarily driven by improved operational efficiency and increased leverage of our channel.

In the three months ended December 31, 2024, general and administrative expenses increased $2.2 million, or 19%, as compared with the same period in fiscal 2024 This increase was primarily driven by higher expense in compliance focused outside services related to ongoing projects.

In the three months ended December 31, 2024, research and development expenses decreased $1.1 million, or 12%, as compared with the same period in fiscal 2024 This decrease was the result of the continued consolidation of acquisition costs, and efficiencies realized through improved organization design.

In the three months ended December 31, 2024, restructuring expenses increased $0.8 million, or 170% as compared with the same period in fiscal 2024 The increase was the result of cost reduction initiatives in the current year.

Other Income (Expense)

(dollars in thousands)

Three Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Other income (expense) $967 1% $(1,419) (2)% $2,386 168%

The change in other income (expense), net during the three months ended December 31, 2024 compared with the same period in fiscal 2024 was related primarily to fluctuations in foreign currency exchange rates during the three months ended December 31, 2024.

Interest Expense

(dollars in thousands)

Three Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Interest expense $(6,840) (9)% $(3,937) (5)% $(2,903) 74%

In the three months ended December 31, 2024, interest expense increased $2.9 million, or 74%, as compared with the same period in fiscal 2024 due to a higher effective interest rate on our Term Loan.

Warrant liabilities

(dollars in thousands)

Three Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Change in fair value of warrant liabilities $(61,630) (85)% $4,402 6% $(66,032) (1,500)%

In December 31, 2024, the change in fair value of warrant liabilities increased $66.0 million, or (1,500)%, as compared with the same period in fiscal 2024, due to a lower average stock price in the second fiscal quarter of 2024.

Income Taxes

(dollars in thousands)

Three Months Ended December 31, 2024 % of pretax income 2023 % of pretax income $ Change % Change
Income tax provision $70 —% $510 (5)% $(440) (86)%

The income tax provision for the three months ended December 31, 2024 and 2023 is primarily influenced by foreign and state income taxes. Due to our history of net losses in the United States, the protracted period for utilizing tax attributes in certain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.

Comparison of the Nine Months Ended December 31, 2024 and 2023

Revenue

(dollars in thousands)

Nine Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Product revenue $116,389 54% $138,635 58% $(22,246) (16)%
Service and subscription 90,383 42% 94,229 39% (3,846) (4)%
Royalty 7,592 4% 7,235 3% 357 5%
Total revenue $214,364 100% $240,099 100% $(25,735) (11)%

Product Revenue

In the nine months ended December 31, 2024, product revenue decreased $22.2 million, or 16%, as compared to the same period in fiscal 2024. The primary driver of the decrease was a $20 million decrease in demand from our large hyperscale customers, as well as more general decreases in the overall tape market with declines in media and devices revenue. Outside of the Tape and Hyperscale business, our remaining Secondary and Primary storage systems are also offered as a subscription. We expect the product revenue portion of our Primary and Secondary storage systems to decrease as we continue to transition to subscription-based offerings.

Service and Subscription Revenue

We offer a broad range of services including product maintenance, implementation, and training as well as software subscriptions. Service revenue is primarily comprised of customer field support contracts which provide standard support services for our hardware. Standard service contracts may be extended or include enhanced service, such as faster service response times.

Service and subscription revenue decreased $3.8 million, or 4%, in the nine months ended December 31, 2024 compared to the same period in fiscal 2024. This decrease was primarily driven by certain long-lived products reaching their end-of-service-life, partially offset by increases in subscription-based revenue.

Royalty Revenue

We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue saw a small increase of $0.4 million, or 5%, in the three months ended December 31, 2024 compared to the same period in fiscal 2024 due to product mix.

Gross Profit and Margin

(dollars in thousands)

Nine Months Ended December 31, 2024 Gross margin % 2023 Gross margin % $ Change Basis point change
Product $23,137 19.9% $33,421 24.1% $(10,284) (420)
Service and subscription 56,428 62.4% 56,900 60.4% (472) 200
Royalty 7,592 100.0% 7,235 100.0% 357 —
Gross profit $87,157 40.7% $97,556 40.6% $(10,399) 10

Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.

Product Gross Margin

Product gross margin decreased 420 basis points, for the nine months ended December 31, 2024, as compared with the same period in fiscal 2024. This decrease was primarily due to a less favorable mix of revenues, weighted towards our lower margin product lines, which were partially offset from improvements in our operational efficiency and logistics costs.

Service and Subscription Gross Margin

Service and subscription gross margin increased 200 basis points for the nine months ended December 31, 2024, as compared with the same period in fiscal 2024. This increase was primarily driven by lowered operation costs as we continue to drive efficiencies.

Royalty Gross Margin

Royalties do not have significant related cost of sales.

Operating Expenses

(dollars in thousands)

Nine Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Sales and marketing $39,321 18% $45,800 19% $(6,479) (14)%
General and administrative 49,186 23% 34,833 15% 14,353 41%
Research and development 24,255 11% 28,828 12% (4,573) (16)%
Restructuring charges 2,916 1% 3,164 1% (248) (8)%
Total operating expenses $115,678 54% $112,625 47% $3,053 3%

In the nine months ended December 31, 2024, sales and marketing expense decreased $6.5 million, or 14%, compared with the same period in fiscal 2024. This decrease was primarily driven by improved operational efficiency and increased leverage of our channel.

In the nine months ended December 31, 2024, general and administrative expense increased $14.4 million, or 41%, compared with the same period in fiscal 2024. This increase was primarily driven by non-recurring costs related to our previously announced restatement of our historical financial statements, and other related projects.

In the nine months ended December 31, 2024, research and development expenses decreased $4.6 million, or 16%, as compared with the same period in fiscal 2024. This decrease was the result of the continued consolidation of acquisition costs, and efficiencies realized through improved organization design.

In the nine months ended December 31, 2024, restructuring expenses decreased $0.2 million, or 8%, as compared with the same period in fiscal 2024. The decrease was the result of cost reduction initiatives in the prior year.

Other Income (Expense)

(dollars in thousands)

Nine Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Other income (expense) $(408) 0% $(2,049) (1)% $1,641 80%

The change in other income (expense), net during the nine months ended December 31, 2024 compared with the same period in fiscal 2024 was related primarily to fluctuations in foreign currency exchange rates during the three months ended December 31, 2024.

Interest Expense

(dollars in thousands)

Nine Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Interest expense $(16,761) (8)% $(10,992) (5)% $(5,769) 52%

In the nine months ended December 31, 2024, interest expense increased $5.8 million, or 52%, as compared with the same period in fiscal 2024 due to a higher effective interest rate on our Term Loan.

Warrant liabilities

(dollars in thousands)

Nine Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Change in fair value of warrant liabilities $(56,414) (26)% $7,341 3% $(63,755) (868)%

In December 31, 2024, the change in fair value of warrant liabilities increased $63.8 million, or 868%, as compared with the same period in fiscal 2024 due to a lower average stock price in the second fiscal quarter of 2024.

Loss on Debt Extinguishment

(dollars in thousands)

Nine Months Ended December 31, 2024 % of revenue 2023 % of revenue $ Change % Change
Loss on debt extinguishment $(3,003) 1% $— —% $(3,003) 100%

In the nine months ended December 31, 2024, loss on debt extinguishment was related to a prepayment of our Term Loan.

Income Taxes

(dollars in thousands)

Nine Months Ended December 31, 2024 % of pretax income 2023 % of pretax income $ Change % Change
Income tax provision $675 (1)% $1,573 (8)% $(898) (57)%

The income tax provision for the nine months ended December 31, 2024 and 2023 is primarily influenced by foreign and state income taxes. Due to our history of net losses in the United States, the protracted period for utilizing tax attributes in certain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.

LIQUIDITY AND CAPITAL RESOURCES

We consider liquidity in terms of the sufficiency of internal and external cash resources to fund our operating, investing and financing activities. Our principal sources of liquidity include cash from operating activities, cash and cash equivalents on our balance sheet and amounts available under our revolving credit facility agreement with PNC Bank, National Association, as amended from time to time (the “PNC Credit Facility”). We require significant cash resources to meet obligations to pay principal and interest on our outstanding debt, provide for our research and development activities, fund our working capital needs, and make capital expenditures. Our future liquidity requirements will depend on multiple factors, including our research and development plans and capital asset needs.

We had cash and cash equivalents of $20.4 million as of December 31, 2024, which consisted primarily of bank deposits and money market accounts. As of December 31, 2024, our total outstanding Term Loan debt was $105.9 million and PNC Credit Facility borrowings were $37.5 million. As of December 31, 2024, we had $1.6 million available to borrow under the PNC Credit Facility.

We are subject to various debt covenants under our debt agreements. Our failure to comply with our debt covenants could materially and adversely affect our financial condition and ability to service our obligations. As discussed in Note 1: Description of Business and Significant Accounting Policies—Going Concern, we expect to be in violation of our net leverage covenant as of the June 30, 2025 testing date and the violation will cause the outstanding Term Loan and PNC Credit Facility outstanding balances to become due as an event of default. As a result, we have classified the Term Loan and PNC Credit Facility as current liabilities in the accompanying consolidated balance sheet. We entered into a Standby Equity Purchase Agreement (the “SEPA”) on January 25, 2025, pursuant to which we have a right, but not the obligation, to sell up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA. See Note 12: Subsequent Events for additional information related to the SEPA. Additionally, the Company is evaluating strategies to obtain the additional funding, including potential covenant waivers. We may be unable to obtain additional funding. As such, there can be no assurance that we will be able to obtain additional liquidity when needed or under acceptable terms, if at all. For additional information about our debt, see the sections entitled “Risk Factors—Risks Related to Our Indebtedness” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” in the Annual Report.

Cash Flows

The following table summarizes our consolidated cash flows for the periods indicated.

(in thousands)

Cash provided by (used in): Nine Months Ended December 31, 2024 2023
Operating activities $(20,345) $(20,727)
Investing activities (4,324) (5,025)
Financing activities 19,415 24,138
Effect of exchange rate changes (3) (12)
Net decrease in cash, cash equivalents and restricted cash $(5,257) $(1,626)

Cash Used In Operating Activities

Net cash used in operating activities was $20.3 million for the nine months ended December 31, 2024. This use of cash was primarily attributed to lower earnings.

Net cash used in operating activities was $20.7 million for the nine months ended December 31, 2023. This use of cash was primarily attributed to cash used in operations excluding changes in assets and liabilities of $8.0 million in addition to cash used from working capital changes.

Cash Used in Investing Activities

Net cash used in investing activities was $4.3 million in the nine months ended December 31, 2024, which was attributable to capital expenditures.

Net cash used in investing activities was $5.0 million in the nine months ended December 31, 2023, which was attributable to capital expenditures.

Cash Provided by Financing Activities

Net cash provided by financing activities was $19.4 million for the nine months ended December 31, 2024, which was related primarily to borrowings on our Term Loan.

Net cash provided by financing activities was $24.1 million for the nine months ended December 31, 2023, which was related primarily to borrowings on the PNC Credit Facility of $14.6 million and borrowing on our Term Loan of $9.6 million net of issuance costs.

Commitments and Contingencies

Our contingent liabilities consist primarily of certain financial guarantees, both express and implied, related to product liability and potential infringement of intellectual property. We have little history of costs associated with such indemnification requirements and contingent liabilities associated with product liability may be mitigated by our insurance coverage. In the normal course of business to facilitate transactions of our services and products, we indemnify certain parties with respect to certain matters, such as intellectual property infringement or other claims. We also have indemnification agreements with our current and former officers and directors. It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of our indemnification claims, and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these agreements have not had a material impact on our operating results, financial position or cash flows.

We are also subject to ordinary course litigation.

Off Balance Sheet Arrangements

Except for the indemnification commitments described under “Commitments and Contingencies” above, we do not currently have any other off-balance sheet arrangements and do not have any holdings in variable interest entities.

Contractual Obligations

We have contractual obligations and commercial commitments, some of which, such as purchase obligations, are not recognized as liabilities in our financial statements. There have not been any material changes to the contractual obligations disclosed in the Annual Report.

Critical Accounting Estimates and Policies

The preparation of our consolidated financial statements in accordance with generally accepted accounting principles requires management to make judgments, estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes included elsewhere in this Quarterly Report. On an ongoing basis, we evaluate estimates, which are based on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. We consider certain accounting policies to be critical to understanding our financial statements because the application of these policies requires significant judgment on the part of management, which could have a material impact on our financial statements if actual performance should differ from historical experience or if our assumptions were to change. Our accounting policies that include estimates that require management’s subjective or complex judgments about the effects of matters that are inherently uncertain are summarized in the Annual Report under the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates and Policies.” For additional information on our significant accounting policies, see Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.

Recently Issued and Adopted Accounting Pronouncements

See Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.

Market risk

As filed, 299 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to our quantitative and qualitative disclosures about market risk from those described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Form 10-K, which such section is incorporated herein by reference.

Controls and procedures

As filed, 4,929 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive and principal financial officers, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)), as of the end of the period covered by this Quarterly Report. Based on such evaluation, our principal executive and principal financial officers have concluded that as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses described below.

Notwithstanding the identified material weaknesses, management, including our chief executive officer and chief financial officer have determined, that the condensed consolidated financial statements included in this Form 10-Q fairly represent in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, for the periods presented in accordance with U.S. generally accepted accounting principles.

Material Weaknesses in Internal Control Over Financial Reporting

The following material weaknesses in our internal control over financial reporting, as initially disclosed in Part II, Item 9A, “Controls and Procedures” of our Annual Report on Form 10-K for the year ended March 31, 2024 had not been remediated as of December 31, 2024. Specifically:

  • The Company’s accounting practices and procedures for applying standalone selling price under Accounting Standards Codification Topic 606 Revenue from Contracts with Customers (“Topic 606”) were not adequate to conclude on the application of standalone selling price consistent with the generally accepted application of the guidance in Topic 606.
  • The Company did not maintain effective controls over the accuracy of the inputs in the sales order entry process to ensure accuracy of the price, quantity, and related customer data.

Remediation Plan

The Company is implementing enhancements to its internal controls to remediate these material weaknesses in its internal control over financial reporting, including:

  • Review and update significant relevant accounting policies, procedures and controls.
  • Provide additional training to individuals involved in the assessments for these topics.
  • Engage with external third parties to assist with assessments for these topics, where necessary.

The Company is committed to maintaining a strong internal control environment and believes the remediation efforts, will represent significant improvements in its controls over the control environment. These steps will take time to be fully implemented and confirmed to be effective and sustainable. Additional controls may also be required over time. While the Company believes that these efforts will improve its internal control over financial reporting, the Company will not be able to conclude whether the steps the Company is taking will remediate the material weakness in internal control over financial reporting until a sufficient period has passed to allow management to test the design and operational effectiveness of the new and enhanced controls. Until the remediation steps set forth above are fully implemented and tested, the material weaknesses will continue to exist.

Changes in Internal Control

Except for the ongoing remediation measures to address the remaining material weaknesses, in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act, there were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Risk factors

As filed, 2,767 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Except as set forth below, there have been no material changes to the previously disclosed risk factors discussed in “Part I, Item 1A, Risk Factors” in the Annual Report. You should consider carefully these factors, together with all of the other information in this Quarterly Report, including our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, before making an investment decision.

It is not possible to predict the actual number of shares we will sell under the SEPA, or the actual gross proceeds resulting from those sales.

On January 25, 2025, we entered into the SEPA with YA, pursuant to which YA committed to purchase up to $200.0 million in shares of our Common Stock, subject to certain limitations and conditions.

We generally have the right to control the timing and amount of any sales of our shares of Common Stock to YA under the SEPA. Because the purchase price per share to be paid by YA for the shares of Common Stock that we may elect to sell to YA under the SEPA will fluctuate based on the market prices of our Common Stock during the applicable purchase valuation period for each purchase made pursuant to the SEPA, it is not possible for us to predict the total number of shares of Common Stock that we will sell to YA under the SEPA, the purchase price per share that YA will pay for shares purchased from us in the future under the SEPA, or the aggregate gross proceeds that we will receive from those purchases by YA under the SEPA. Sales of shares of our Common Stock pursuant to the SEPA will be dilutive to stockholders.

Moreover, although the SEPA provides that we may sell up to an aggregate of $200.0 million of our Common Stock to YA, only 2,302,733 shares of our Common Stock under the SEPA are being registered for resale by YA, which registration statement on Form S-1 filed with the SEC on January 27, 2025, as amended (as amended, the “Registration Statement”), has not yet been declared effective. If it becomes necessary for us to issue and sell to YA under the SEPA more than the shares that are being registered for resale under the Registration Statement in order to receive aggregate gross proceeds equal to the total commitment of aggregate of $200.0 million under the SEPA, we must file with the SEC one or more additional registration statements to register under the Securities Act of 1933 the resale by YA of any such additional shares of our Common Stock we wish to sell from time to time under the SEPA, which the SEC must declare effective and we may need to obtain stockholder approval to issue shares of Common Stock in excess of the exchange cap under the SEPA in accordance with applicable listing rules of The Nasdaq Stock Market.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-10-01 to 2024-12-31$72.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2024-04-01 to 2024-12-31$214.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2024-10-01 to 2024-12-31$40.8mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2024-04-01 to 2024-12-31$127.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2024-10-01 to 2024-12-31$31.8mus-gaap:GrossProfit
Gross profit9 months2024-04-01 to 2024-12-31$87.2mus-gaap:GrossProfit
Research and development3 months2024-10-01 to 2024-12-31$7.7mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2024-04-01 to 2024-12-31$24.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2024-10-01 to 2024-12-31−$3.9mus-gaap:OperatingIncomeLoss
Operating income9 months2024-04-01 to 2024-12-31−$28.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2024-10-01 to 2024-12-31$6.8mus-gaap:InterestExpenseNonoperating
Interest expense9 months2024-04-01 to 2024-12-31$16.8mus-gaap:InterestExpenseNonoperating
Income tax3 months2024-10-01 to 2024-12-31$70.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-04-01 to 2024-12-31$675.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-10-01 to 2024-12-31−$71.4mus-gaap:NetIncomeLoss
Net income9 months2024-04-01 to 2024-12-31−$105.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-10-01 to 2024-12-31−$14.56us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-04-01 to 2024-12-31−$21.90us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-10-01 to 2024-12-31−$14.56us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-04-01 to 2024-12-31−$21.90us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-10-01 to 2024-12-314,907,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-04-01 to 2024-12-314,831,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-04-01 to 2024-12-31−$20.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2024-04-01 to 2024-12-31$4.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2024-12-31$20.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-12-31$113.8mus-gaap:AssetsCurrent
Total assetsAt period end2024-12-31$168.1mus-gaap:Assets
Current liabilitiesAt period end2024-12-31$305.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-12-31$363.1mus-gaap:Liabilities
Long-term debtAt period end2024-12-31$0us-gaap:LongTermDebt
Current portion of debtAt period end2024-12-31$98.6mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2024-12-31−$195.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000709283-25-000003. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.